• 1. End-ligation can dramatically stabilize i-motifs at neutral pH
  Roberto El-Khoury,Masad J. Damha Chem. Commun. 2023 59 3715
• 2. New strategies and applications using electrophilic cyanide-transfer reagents under transition metal-free conditions
  Johannes Sch?rgenhumer,Mario Waser Org. Chem. Front. 2016 3 1535
• 3. Functional evolution on the assembled DNA template
  Lijin Xu,Dongsheng Liu Chem. Soc. Rev. 2010 39 150
• 4. Synthesis of imidazole-activated ribonucleotides using cyanogen chloride
  Ruiqin Yi,Yayoi Hongo,Albert C. Fahrenbach Chem. Commun. 2018 54 511
• 5. G-quadruplex as a new class of structural entities for directing the formation of circular oligodeoxyribonucleotides
  Jian Chen,Dongsheng Liu,Alex H. F. Lee,Jianying Qi,Albert S. C. Chan,Tianhu Li Chem. Commun. 2002 2686

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

1-Cyanoimidazole: A Comprehensive Overview

1-Cyanoimidazole, also known by its CAS number No36289-36-8, is a heterocyclic organic compound that has garnered significant attention in the fields of organic chemistry, pharmacology, and materials science. This compound, with the molecular formula C4H3N3, is characterized by its imidazole ring substituted with a cyano group at the 1-position. The compound exhibits a wide range of applications due to its unique chemical properties and reactivity.

The synthesis of 1-Cyanoimidazole can be achieved through various methods, including the reaction of imidazole derivatives with nitriles under specific conditions. Recent studies have focused on optimizing these synthetic routes to enhance yield and purity. For instance, researchers have explored the use of microwave-assisted synthesis to accelerate the reaction process, which has shown promising results in terms of efficiency and selectivity.

1-Cyanoimidazole has been extensively studied for its potential in drug design. The compound's ability to act as a hydrogen bond donor and acceptor makes it an ideal candidate for targeting various biological molecules. Recent research has highlighted its role as a potential inhibitor of key enzymes involved in diseases such as cancer and neurodegenerative disorders. For example, a study published in 2023 demonstrated that 1-Cyanoimidazole-based compounds exhibit significant inhibitory activity against histone deacetylases (HDACs), which are implicated in cancer progression.

In addition to its pharmacological applications, 1-Cyanoimidazole has found utility in materials science. The compound's ability to coordinate with metal ions has led to its use in the synthesis of metal-organic frameworks (MOFs) and coordination polymers. These materials exhibit exceptional properties such as high surface area and porosity, making them suitable for gas storage and catalysis applications. Recent advancements in this area have focused on incorporating 1-Cyanoimidazole into MOFs to enhance their stability and functionality under various environmental conditions.

The chemical versatility of 1-Cyanoimidazole extends to its role as a building block in organic synthesis. The compound serves as an efficient precursor for the construction of complex heterocyclic frameworks, which are valuable in drug discovery and materials development. Researchers have also explored the use of 1-Cyanoimidazole in click chemistry reactions, where it acts as a reactive component for the formation of stable covalent bonds. This approach has been particularly useful in the synthesis of bioactive molecules with intricate architectures.

No36289-36-8, or 1-Cyanoimidazole, continues to be a subject of intense research due to its diverse applications and potential for further innovation. As advancements in synthetic methodologies and materials science continue to unfold, the significance of this compound is expected to grow further. Its role in drug design, materials development, and organic synthesis underscores its importance as a key molecule in modern chemistry.

• 4166-68-1(1-methylimidazole-d3 (ring-d3))
• 285978-27-0(1-Methylimidazole-d)
• 616-47-7(1-Methylimidazole)
• 16650-76-3(1-Methylimidazole-d3)
• 30346-87-3(1H-Imidazole, methyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)